Iproteos Overview

  • Founded
  • 2011

Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Iproteos General Information

Description

Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The company's therapy specializes in the research and development of third-generation drugs, such as protein-protein interactions (PPIs), enabling medical professionals to treat schizophrenia, epilepsy, pediatric cancer and other neurological disorders.

Contact Information

Website
www.iproteos.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Accure Therapeutics
Primary Office
  • Baldiri Reixac, 10
  • Barcelona Science Park
  • 08028 Barcelona
  • Spain
+34 934 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iproteos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 28-May-2020 00.000 Completed Generating Revenue
7. Early Stage VC (Series A) 15-Jul-2018 00.000 Completed Generating Revenue
6. Grant 29-May-2017 00.000 Completed Generating Revenue
5. Seed Round 25-Oct-2016 00.000 00.000 Completed Pre-Clinical Trials
4. Equity Crowdfunding 26-Sep-2016 00000 00000 Completed Pre-Clinical Trials
3. Equity Crowdfunding 01-Nov-2014 00000 00000 Completed Startup
2. Grant 01-Jan-2014 $686K $144K Completed Startup
1. Capitalization 01-Jan-2012 $144K $144K Completed Startup
To view Iproteos’s complete valuation and funding history, request access »

Iproteos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The
Drug Discovery
Barcelona, Spain
00.000
000000&0 00.000

000000

si ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000 000000000
Barcelona, Spain
00 As of 0000
00000
000000 - 000 00000

00000

ore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000 000000000
Grove City, OH
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Iproteos Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Minoryx Venture Capital-Backed Barcelona, Spain 00 00000 000000 - 000 00000
00000 000000000 Venture Capital-Backed Grove City, OH 000 00000 00000000000 00000
0000000000 0000000 Formerly VC-backed Novato, CA 0000 00000 000000000 00000
0000 0000000 00000 Corporation Franklin, TN 00
00000 000000 Formerly VC-backed Austin, TX 00 0000 000000 - 000 0000
You’re viewing 5 of 25 competitors. Get the full list »

Iproteos Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ASCIL Biopharm Other Minority 000 0000 000000 0
Caixa Capital Risc Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Kinled Holding Venture Capital Minority 000 0000 000000 0
Ministerio de Economía, Industria y Competitividad Government 000 0000 000000 0
To view Iproteos’s complete investors history, request access »

Ready to get started?

Request a free trial